OncoCyte Corporation (NASDAQ:OCX) Q2 2023 Earnings Call Transcript

OncoCyte Corporation (NASDAQ:OCX) Q2 2023 Earnings Call Transcript August 10, 2023

OncoCyte Corporation beats earnings expectations. Reported EPS is $-1.07, expectations were $-2.6.

Operator: Welcome to the OncoCyte Q2 2023 Earnings Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over...